Medical Photobiostimulation System Market to Outstrip $314.88 Million by 2028 Growing Sturdy at 6.3% CAGR - COVID-19 Impact and Global Analysis by TheInsightPartners.com
12 août 2021 09h39 HE
|
The Insight Partners
Pune, INDIA., Aug. 12, 2021 (GLOBE NEWSWIRE) -- Medical Photobiostimulation System Market: Key InsightsAccording to our new research study on “Medical Photobiostimulation System Market to 2028 –...
Leaf411: Increase in Opioid-related Overdoses Creates Urgency to Educate on Cannabis Treatments for Chronic Pain
10 août 2021 11h00 HE
|
The 9th Block
DENVER, Aug. 10, 2021 (GLOBE NEWSWIRE) -- According to the U.S. Department of Health and Human Services, two-thirds of all drug overdoses in the country involve an opioid, and overdose deaths...
Canada’s surgery backlog could lead to wave of new chronic pain and opioid dependencies
21 juil. 2021 06h00 HE
|
Inagene Diagnostics Inc.
TORONTO, July 21, 2021 (GLOBE NEWSWIRE) -- As Canada’s vaccination rates climb and hospitals begin to tackle the mountain of postponed surgeries due to the pandemic, we are facing an echo epidemic...
Multi-Center Study of SPRINT® PNS System for Chronic Low Back Pain Demonstrates Clinically Significant Improvements in Pain and Quality of Life
12 juil. 2021 08h00 HE
|
SPR Therapeutics, Inc.
CLEVELAND, July 12, 2021 (GLOBE NEWSWIRE) -- In the largest, most rigorous study to date using the SPRINT® PNS System for chronic axial low back pain (LBP), patients that failed to find relief from...
InvestorBrandNetwork (IBN) Announces Latest Episode of Stock2Me Podcast featuring Tryp Therapeutics Inc. Chairman and CEO Greg McKee
17 juin 2021 08h17 HE
|
InvestorBrandNetwork (IBN)
LOS ANGELES, June 17, 2021 (GLOBE NEWSWIRE) -- (via InvestorWire) InvestorBrandNetwork (“IBN”), a multifaceted communications organization engaged in connecting public companies to the investment...
NeuroMetrix Announces That Top-Line Results from a Randomized Controlled Trial of Quell® for Treatment of Fibromyalgia to be Presented at Two Upcoming Pain Medicine Conferences
09 juin 2021 08h00 HE
|
NeuroMetrix, Inc.
WOBURN, Mass., June 09, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported that top-line results from a randomized controlled trial of Quell in patients with fibromyalgia will...
Shades for Migraine Partners with Rising Influencers to Empower People with Migraine
25 mai 2021 09h03 HE
|
Association of Migraine Disorders
Rhode Island, May 25, 2021 (GLOBE NEWSWIRE) -- Providence, R.I. (May 25, 2021) – Global awareness campaign, Shades for Migraine®, teams up with two rising social media influencers, YouTuber,...
Green Hygienics Holdings Inc. (GRYN) Executes Agreement with Cinvestav, the Leading Mexican Academic Research Institution, to Advance Research Targeting Endocannabinoid System (ECS) Deficiencies
20 mai 2021 08h30 HE
|
Green Hygienics Holdings Inc.
SAN DIEGO, May 20, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Green Hygienics Holdings Inc. (OTCQB: GRYN) ("Green Hygienics" or the "Company") is pleased to announce it has entered into a...
NeuroMetrix Reports Q1 2021 Financial Results
22 avr. 2021 07h00 HE
|
NeuroMetrix, Inc.
WOBURN, Mass., April 22, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended March 31, 2021. The Company is a leader in...
NeuroMetrix, Inc. Announces Date for First Quarter 2021 Financial Results Conference Call
15 avr. 2021 13h00 HE
|
NeuroMetrix, Inc.
WOBURN, Mass., April 15, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2021 first quarter financial results before the opening of the market on...